Three Leadership Lessons Being a Veteran Taught Me Veteran’s Day is a time for us to honor those who served our country in the armed forces. It is a day that holds special meaning to… Read more >
Recently, Fabrice Gritti, Principal Consulting Scientist at Waters, was featured in the Analytical Scientist’s annual Power List, which recognizes talent, ingenuity and leadership across all corners of analytical science on a global scale. We sat… Read more >
On October 2, 2019, Waters proudly opened our new Swedish head office and laboratory in the House of Innovations, located in the center of Campus Solna next to Karolinska Institutet. The new facility features an… Read more >
This blog was originally posted on LinkedIn Today we’re celebrating the 94th birthday of a scientific genius and corporate culture visionary. Jim Waters, the founder of Waters Corporation, is a legendary innovator and entrepreneur. He… Read more >
As a science-based organization, STEM education is of the utmost importance to Waters. This blog highlights the excitement of its partnership with Junior Achievement, one of the world’s largest youth-serving NGOs that prepares young people for employment and entrepreneurship.
Confronting the challenge of sensitivity and sample loss As a relative newcomer to peptide and protein quantification coming from the small molecule world, I have learned that I need to think differently, and more creatively,… Read more >
My sample stayed in the solution…or did it? Samples are precious. Well-prepared samples are the starting point of all successful experiments. That’s why we spend time and effort on sample preparation; so that the resulting… Read more >
The 30th James L. Waters Annual Symposium will take place on Monday, March 18 in Philadelphia as part of Pittcon 2019. The theme of this year’s Symposium focuses on early research efforts required to develop… Read more >
Non-specific binding of protein and peptides continues to plague scientists with low recovery. high variability, and poor sensitivity. Are you doing enough to combat non-specific binding?
Waters recently surveyed 100 method developers from innovator and generic pharmaceutical companies to better understand their existing challenges and views on Method Lifecycle Management (MLCM). We’ll share with you the top questions and findings from our survey results.
